NRX Pharmaceuticals, Inc. Share Price
NRXPNRX Pharmaceuticals, Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
NRX Pharmaceuticals, Inc. Share Price Chart
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|
FAQs on NRX Pharmaceuticals, Inc. Share Price
Can I buy NRX Pharmaceuticals, Inc. shares in India?
What is the share price of NRX Pharmaceuticals, Inc.?
What is the 5 year returns of NRX Pharmaceuticals, Inc.?
What are the high & low stock price of NRX Pharmaceuticals, Inc. today?
What is the 52-week high and low of NRX Pharmaceuticals, Inc. stock?